Aquestive Therapeutics, Inc. (AQST)
4.57
-0.04
(-0.87%)
USD |
NASDAQ |
Oct 07, 14:23
Aquestive Therapeutics Debt to Equity Ratio : -2.635 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.635 |
| March 31, 2026 | -3.922 |
| December 31, 2025 | -3.905 |
| September 30, 2025 | -31.36 |
| June 30, 2025 | -1.739 |
| March 31, 2025 | -2.044 |
| December 31, 2024 | -2.027 |
| September 30, 2024 | -2.630 |
| June 30, 2024 | -3.294 |
| March 31, 2024 | -3.172 |
| December 31, 2023 | -0.928 |
| September 30, 2023 | -1.064 |
| June 30, 2023 | -1.027 |
| March 31, 2023 | -1.041 |
| December 31, 2022 | -1.035 |
| September 30, 2022 | -1.116 |
| June 30, 2022 | -1.238 |
| March 31, 2022 | -1.277 |
| Date | Value |
|---|---|
| December 31, 2021 | -1.421 |
| September 30, 2021 | -1.689 |
| June 30, 2021 | -1.808 |
| March 31, 2021 | -1.810 |
| December 31, 2020 | -1.844 |
| September 30, 2020 | -1.802 |
| June 30, 2020 | -3.059 |
| March 31, 2020 | -3.118 |
| December 31, 2019 | -9.856 |
| September 30, 2019 | -1.735 |
| June 30, 2019 | -1.924 |
| March 31, 2019 | -7.859 |
| December 31, 2018 | 4.683 |
| September 30, 2018 | 1.996 |
| June 30, 2018 | -1.192 |
| March 31, 2018 | -2.052 |
| December 31, 2017 | -1.718 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| LENZ Therapeutics, Inc. | 0.0026 |
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
| Veru, Inc. | 0.0945 |
| Johnson & Johnson | 0.5771 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 132.10M |
| Total Liabilities (Quarterly) | 188.69M |
| Shareholders Equity (Quarterly) | -56.59M |
| Current Ratio | 7.191 |
| Net Debt Paydown Yield | -0.94% |